A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia
Clinical trial NCT03092726 · COMPLETED
Trial details
- NCT number
- NCT03092726
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2018-03-06
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.